...
首页> 外文期刊>Circulation: An Official Journal of the American Heart Association >Gap junction blockers decrease defibrillation thresholds without changes in ventricular refractoriness in isolated rabbit hearts.
【24h】

Gap junction blockers decrease defibrillation thresholds without changes in ventricular refractoriness in isolated rabbit hearts.

机译:间隙连接阻滞剂可降低除颤阈值,而不会改变离体兔心脏的心室不应性。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

BACKGROUND: The maintenance and termination of reentry arrhythmias are determined by tissue properties such as refractoriness and conduction velocity. Although the effects of Na(+) and K(+) channel block on electrophysiological properties and defibrillation threshold (DFT) have been studied, little is known about the effect of gap junction blockers on defibrillation and tissue electrophysiological properties. METHODS AND RESULTS: Triplicate DFTs (volts) were obtained before and 15 minutes after 4 micromol/L 16-doxyl-stearic acid (16-DSA, n=8), 1 mmol/L 1-heptanol (n=12) (both gap junction blockers), 3 microg/mL lidocaine (a sodium channel blocker) (n=8), and respective controls (n=27) in isolated perfused rabbit hearts. DFT decreased after 16-DSA (23+/-14%, P<0.01) and 1-heptanol (21+/-16%, P<0.01) but increased after lidocaine (26+/-28%, P<0.05). Ventricular fibrillation cycle length (VFCL) and QRS duration increased after all 3 agents, by 36+/-19% and 44+/-16% (16-DSA), 87+/-42% and 49+/-15% (heptanol), and 57+/-20% and 43+/-26% (lidocaine), respectively (all P<0.01). Spatially averaged temporal VFCL dispersion decreased significantly after all 3 agents, by 47+/-42% (16-DSA, P<0.05), 74+/-19% (1-heptanol, P<0.01), and 82+/-13% (lidocaine, P<0.01), respectively. Ventricular effective refractory period and monophasic action potential duration at 90% repolarization were unchanged after 16-DSA and 1-heptanol (P=NS) but increased after lidocaine (16+/-13%, P<0.01, and 6+/-5%, P=NS, respectively). There were no significant changes in DFT or any other electrophysiological variable in control hearts. CONCLUSIONS: Electrical uncoupling by 16-DSA and 1-heptanol significantly lowers DFT and dispersion of VFCL without altering refractoriness; lidocaine, at doses resulting in similar slowing of conduction, increases DFT.
机译:背景:折返性心律不齐的维持和终止取决于组织的性质,例如难治性和传导速度。尽管已研究了Na(+)和K(+)通道阻滞对电生理特性和除颤阈值(DFT)的影响,但对间隙连接阻滞剂对除颤和组织电生理特性的影响知之甚少。方法和结果:在4 micromol / L 16-doxyl-硬脂酸(16-DSA,n = 8),1 mmol / L 1-庚醇(n = 12)之前和之后15分钟获得一式三份的DFT(伏特)。间隙连接阻滞剂),3 microg / mL利多卡因(一种钠通道阻滞剂)(n = 8)和各自的对照(n = 27)在离体灌流的兔心脏中。 16-DSA(23 +/- 14%,P <0.01)和1-庚醇(21 +/- 16%,P <0.01)后DFT降低,但利多卡因后(26 +/- 28%,P <0.05)后DFT升高。在全部3种药物后,心室纤颤周期长度(VFCL)和QRS持续时间增加了36 +/- 19%和44 +/- 16%(16-DSA),87 +/- 42%和49 +/- 15%(庚醇)和57 +/- 20%和43 +/- 26%(利多卡因)(所有P <0.01)。在全部3种药物治疗后,空间平均时间VFCL离散度均显着降低,分别降低47 +/- 42%(16-DSA,P <0.05),74 +/- 19%(1-庚醇,P <0.01)和82 +/-分别为13%(利多卡因,P <0.01)。在16-DSA和1-庚醇(P = NS)后,心室有效不应期和复相90%时的单相动作电位持续时间不变,但在利多卡因后增加(16 +/- 13%,P <0.01和6 +/- 5) %,分别为P = NS)。对照心脏的DFT或任何其他电生理变量无明显变化。结论:16-DSA和1-庚醇的电解偶联显着降低了VFCL的DFT和分散性,而不会改变耐火度。利多卡因的剂量会导致类似的传导减慢,从而增加DFT。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号